Phosphoinositide-specific Phospholipase C β1 gene deletion in bipolar disorder affected patient
Vincenza Rita Lo Vasco1, Lucia Longo, Patrizia Polonia
1Dipartimento Organi di Senso, Sapienza University of Rome, Rome, Italy, ritalovasco@hotmail.it.
Abstract:
The involvement of phosphoinositides (PI) signal transduction pathway and related molecules, such as the Phosphoinositide-specific Phospholipase C (PI-PLC) enzymes, in the pathophysiology of mood disorders is corroborated by a number of recent evidences. Our previous works identified the deletion of PLCB1 gene, which codifies for the PI-PLC β1 enzyme, in 4 out 15 patients affected with schizophrenia, and no deletion both in major depression affected patients and in normal controls. By using interphase fluorescent in situ hybridization methodology, we analyzed PLCB1 in paraffin embedded samples of orbito-frontal cortex of 15 patients affected with bipolar disorder. Deletion of PLCB1 was identified in one female patient.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Bipolar Disorder
IP3/DAG Signaling Pathway
Pedigree Analysis
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
EPS and iPS Cells in Disease Research


